Brintellix® (vortioxetine) for the treatment of major depressive disorder in adults is now available in U.S. pharmacies

13:53 EST 22 Jan 2014 | Takeda

Valby, Denmark, 21 January 2014 and Osaka, Japan, 22 January 2014 - H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) jointly announced today that Brintellix (vortioxetine), for the treatment of major depressive disor...

Original Article: Brintellix® (vortioxetine) for the treatment of major depressive disorder in adults is now available in U.S. pharmacies

NEXT ARTICLE

More From BioPortfolio on "Brintellix® (vortioxetine) for the treatment of major depressive disorder in adults is now available in U.S. pharmacies"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement